- Home
- SGRY vs WLY Comparison
SGRY vs WLY Comparison
Compare SGRY & WLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGRY
- WLY
- Stock Information
- Founded
- SGRY 2004
- WLY 1807
- Country
- SGRY United States
- WLY United States
- Employees
- SGRY N/A
- WLY N/A
- Industry
- SGRY Hospital/Nursing Management
- WLY Books
- Sector
- SGRY Health Care
- WLY Consumer Discretionary
- Exchange
- SGRY Nasdaq
- WLY Nasdaq
- Market Cap
- SGRY 2.7B
- WLY 2.7B
- IPO Year
- SGRY 2015
- WLY N/A
- Fundamental
- Price
- SGRY $21.22
- WLY $44.38
- Analyst Decision
- SGRY Buy
- WLY
- Analyst Count
- SGRY 9
- WLY 0
- Target Price
- SGRY $37.38
- WLY N/A
- AVG Volume (30 Days)
- SGRY 1.3M
- WLY 467.4K
- Earning Date
- SGRY 11-12-2024
- WLY 12-05-2024
- Dividend Yield
- SGRY N/A
- WLY 3.18%
- EPS Growth
- SGRY N/A
- WLY N/A
- EPS
- SGRY N/A
- WLY N/A
- Revenue
- SGRY $2,985,300,000.00
- WLY $1,759,570,000.00
- Revenue This Year
- SGRY $14.46
- WLY N/A
- Revenue Next Year
- SGRY $9.94
- WLY $1.12
- P/E Ratio
- SGRY N/A
- WLY N/A
- Revenue Growth
- SGRY 9.96
- WLY N/A
- 52 Week Low
- SGRY $19.50
- WLY $30.45
- 52 Week High
- SGRY $35.30
- WLY $53.96
- Technical
- Relative Strength Index (RSI)
- SGRY 41.64
- WLY 26.68
- Support Level
- SGRY $19.90
- WLY $43.93
- Resistance Level
- SGRY $22.35
- WLY $46.15
- Average True Range (ATR)
- SGRY 1.17
- WLY 1.28
- MACD
- SGRY 0.13
- WLY -0.35
- Stochastic Oscillator
- SGRY 37.80
- WLY 6.34
About SGRY Surgery Partners Inc.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It operates in two segments: Surgical Facility Services and Ancillary Services out of which the Surgical Facility Services segment accounts for the majority of revenue.
About WLY John Wiley & Sons Inc.
John Wiley & Sons Inc is a provider of academic journals, books, pre- and post-hire assessments and training, test preparation materials, and online education program management solutions. The company's reportable segments are; Research, Learning, Held for Sale or Sold. The majority of the company's revenue is generated from the Research segment which provides peer-reviewed scientific, technical, and medical (STM) publishing, content platforms, and related services to academic, corporate, and government customers, academic societies, and individual researchers. Geographically, it derives maximum revenue from the United States and the rest from the United Kingdom, China, Japan, Canada, and other countries.